Ado-trastuzumab emtansine Intravenous and Dihydroergotamine
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Dihydroergotamine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Dihydroergotamine injection
- Ado-trastuzumab emtansine Intravenous-Dihydroergotamine Mesylate
- Ado-trastuzumab emtansine Intravenous-Dihydroergotamine nasal
- Ado-trastuzumab emtansine Intravenous-Dihydroergotamine Nasal Spray
- Ado-trastuzumab emtansine Intravenous-Dilacor XR
- Ado-trastuzumab emtansine Intravenous-Dilantin
- Dihydroergotamine-Adox Pak 2/100
- Dihydroergotamine-Adoxa
- Dihydroergotamine-Adoxa CK
- Dihydroergotamine-Adoxa Pak
- Dihydroergotamine-Adoxa Pak 1/100
- Dihydroergotamine-Adoxa Pak 1/150